TLR4 and Alzheimer disease: Mechanistic studies suggest that the protective effect of FMT on AD may primarily be attributed to its inhibition of the LPS‐TLR4 pathway, which subsequently ameliorates both intestinal and neuroinflammation and suppresses Aβ production.